Loading…
Broach Lifecare Hospital (BSE 544231)₹12.700.00%Hospital
In the Mar 2026 quarter (standalone), Broach Lifecare Hospital reported sales of ₹3.40 Cr, up 146.4% from Mar 2025, and net profit of −₹0.24 Cr, down 340.0% year on year. For the year to Mar 2026, sales were ₹6 Cr and net profit ₹0.10 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 0.91 | 1.71 | 1.82 | 1.38 | 2.61 | 3.40 |
| Expenses | 0.51 | 1.04 | 1.15 | 1.19 | 2.07 | 3.39 |
| Operating Profit | 0.37 | 0.64 | 0.64 | 0.16 | 0.51 | 0.00 |
| OPM % | 42.2% | 38.2% | 35.9% | 12.4% | 20.0% | −0.3% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.06 | 0.05 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.04 | 0.03 | 0.00 |
| Depreciation | 0.07 | 0.00 | 0.05 | 0.06 | 0.10 | 0.18 |
| Profit before tax | 0.29 | 0.63 | 0.58 | 0.11 | 0.40 | −0.19 |
| Tax % | 26.7% | 25.0% | 23.7% | 33.4% | 24.4% | 10.0% |
| Net Profit | 0.23 | 0.48 | 0.45 | 0.10 | 0.32 | −0.24 |
| EPS (Rs) | 0.48 | 1.04 | 0.71 | 0.14 | 0.50 | −0.37 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 3.40 | 1.83 | 2.62 | 3.13 | 6.00 |
| Expenses | 2.10 | 1.05 | 1.57 | 2.28 | 5.47 |
| Operating Profit | 1.27 | 0.77 | 1.02 | 0.82 | 0.50 |
| OPM % | 37.7% | 41.7% | 39.4% | 26.6% | 8.5% |
| Other Income | −0.25 | 0.11 | 0.00 | 0.06 | 0.05 |
| Interest | 0.10 | 0.28 | 0.00 | 0.04 | 0.05 |
| Depreciation | 0.32 | 0.40 | 0.08 | 0.12 | 0.29 |
| Profit before tax | 0.61 | 0.17 | 0.93 | 0.71 | 0.20 |
| Tax % | 25.8% | 27.8% | 25.6% | 25.0% | 57.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.47 | 0.15 | 0.71 | 0.55 | 0.10 |
| EPS (Rs) | — | — | 1.56 | 0.88 | 0.14 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.02 | 0.02 | 4.47 | 6.08 | 6.07 |
| Reserves | 2.25 | 2.16 | 1.01 | 3.29 | 3.38 |
| Borrowings | 2.54 | 5.93 | 0.00 | 1.04 | 0.00 |
| Other Liabilities | 1.11 | 0.08 | 0.24 | 0.50 | 1.30 |
| Total Liabilities | 5.92 | 8.19 | 5.72 | 10.91 | 10.75 |
| Fixed Assets | 4.92 | 6.40 | 1.31 | 1.58 | 4.56 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 3.23 | 0.13 |
| Other Assets | 1.00 | 1.79 | 4.41 | 6.10 | 6.06 |
| Inventories | 0.00 | 0.00 | 0.29 | 0.41 | 0.41 |
| Trade receivables | 0.01 | 0.11 | 0.30 | 0.59 | 0.90 |
| Cash & equivalents | 0.06 | 0.19 | 0.06 | 0.19 | 0.26 |
| Total Assets | 5.92 | 8.19 | 5.72 | 10.91 | 10.75 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 1.12 | −0.96 | −3.32 | −0.63 | 1.31 |
| Cash from investing activity | −2.80 | −1.79 | −1.40 | −3.65 | −0.15 |
| Cash from financing activity | 1.64 | 2.87 | 4.78 | 4.39 | −1.10 |
| Net cash flow | −0.04 | 0.12 | 0.06 | 0.11 | 0.06 |
| Capex | 2.89 | 1.89 | 1.40 | 3.65 | 3.29 |
| Free cash flow | −1.76 | −2.82 | −4.69 | −4.25 | −1.97 |
| CFO / OP % | 98.9% | −118.1% | −321.0% | −75.0% | 254.9% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 2 | 24 | 43 | 70 | 55 |
| Inventory days | 0 | 0 | — | 612 | 90 |
| Days payable | — | — | — | 277 | 190 |
| Cash conversion cycle | 1 | 23 | 42 | 405 | −45 |
| Working capital days | −75 | 25 | 145 | 155 | 129 |
| ROCE % | — | 7.1% | 13.8% | 9.4% | 2.5% |
For the Mar 2026 quarter, Broach Lifecare Hospital reported sales of ₹3.40 Cr, up 146.4% year on year and net profit of −₹0.24 Cr, down 340.0% year on year. The operating margin was −0.3%.
Broach Lifecare Hospital's sales for the year to Mar 2026 were ₹6 Cr.
Net profit for the year to Mar 2026 was ₹0.10 Cr. Earnings per share over the same trailing period were ₹0.14.
Broach Lifecare Hospital reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.26 Cr.
Cash from operations was ₹1.31 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.97 Cr.